Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer

por Volpato, Milene, Hull, Mark A.
Publicado 2018

A risk-stratified approach to colorectal cancer prevention and diagnosis

por Hull, Mark A., Rees, Colin J., Sharp, Linda, Koo, Sara
Publicado 2020

The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid

por Scaioli, Eleonora, Cardamone, Carla, Liverani, Elisa, Munarini, Alessandra, Hull, Mark A., Belluzzi, Andrea
Publicado 2015

Colorectal Cancer Prognosis Following Obesity Surgery in a Population-Based Cohort Study

por Tao, Wenjing, Konings, Peter, Hull, Mark A., Adami, Hans-Olov, Mattsson, Fredrik, Lagergren, Jesper
Publicado 2016

Reduction in the resident intestinal myelomonocytic cell population occurs during Apc(Min/+) mouse intestinal tumorigenesis

por Faluyi, Olusola O., Hull, Mark A., Markham, Alexander F., Bonifer, Constanze, Coletta, P. Louise
Publicado 2021

FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms

por Tomlinson, Darren C., Baxter, Euan W., Loadman, Paul M., Hull, Mark A., Knowles, Margaret A.
Publicado 2012

Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study

por Aravani, Ariadni, Downing, Amy, Thomas, James D., Lagergren, Jesper, Morris, Eva J.A., Hull, Mark A.
Publicado 2018

Beyond cardiovascular medicine: potential future uses of icosapent ethyl

por Bhatt, Deepak L, Hull, Mark A, Song, Mingyang, Van Hulle, Carol, Carlsson, Cindy, Chapman, M John, Toth, Peter P
Publicado 2020

Regional differences in prostaglandin E(2) metabolism in human colorectal cancer liver metastases

por Young, Alastair L, Chalmers, Claire R, Hawcroft, Gillian, Perry, Sarah L, Treanor, Darren, Toogood, Giles J, Jones, Pamela F, Hull, Mark A
Publicado 2013

A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme...

por Hull, Mark A, Sandell, Anna C, Montgomery, Alan A, Logan, Richard FA, Clifford, Gayle M, Rees, Colin J, Loadman, Paul M, Whitham, Diane
Publicado 2013

Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case–control...

por Ingram, Nicola, Northwood, Emma L., Perry, Sarah L., Marston, Gemma, Snowden, Helen, Taylor, John C., Scott, Nigel, Bishop, D. Timothy, Coletta, P. Louise, Hull, Mark A.
Publicado 2013

REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study

por Bradley, Christopher, Hee, Siew Wan, Andronis, Lazaros, Persaud, Krishna, Hull, Mark A, Todd, John, Taylor-Phillips, Sian, Smith, Steve, Constable, Rachel, Waugh, Norman, Arasaradnam, Ramesh P
Publicado 2022

Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?

por Walsh, Elizabeth, Rees, Colin J, Gill, Michael, Parker, Clare E, Bevan, Roisin, Perry, Sarah L, Bury, Yvonne, Mills, Sarah, Bradburn, D Michael, Bramble, Michael, Hull, Mark A
Publicado 2016

Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid

por Volpato, Milene, Ingram, Nicola, Perry, Sarah L, Spencer, Jade, Race, Amanda D, Marshall, Catriona, Hutchinson, John M, Nicolaou, Anna, Loadman, Paul M, Coletta, P Louise, Hull, Mark A
Publicado 2020

Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary Ileostomy

por Nana, Gael, Mitra, Suparna, Watson, Henry, Young, Caroline, Wood, Henry M, Perry, Sarah L, Race, Amanda D, Quirke, Philip, Toogood, Giles J, Loadman, Paul M, Hull, Mark A
Publicado 2021

Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer

por Volpato, Milene, Cummings, Michele, Shaaban, Abeer M., Abderrahman, Balkees, Hull, Mark A., Maximov, Philipp Y., Broom, Bradley M., Hoppe, Reiner, Fan, Ping, Brauch, Hiltrud, Jordan, V. Craig, Speirs, Valerie
Publicado 2020

Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, pl...

por Hull, Mark A, Sprange, Kirsty, Hepburn, Trish, Tan, Wei, Shafayat, Aisha, Rees, Colin J, Clifford, Gayle, Logan, Richard F, Loadman, Paul M, Williams, Elizabeth A, Whitham, Diane, Montgomery, Alan A
Publicado 2018

Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metasta...

por Volpato, Milene, Perry, Sarah L, Marston, Gemma, Ingram, Nicola, Cockbain, Andrew J., Burghel, Heather, Jake, Mann, Lowes, David, Wilson, Erica, Droop, Alastair, Randerson-Moor, Juliette, Coletta, P Louise, Hull, Mark A
Publicado 2016

The COLO‐COHORT (Colorectal Cancer Cohort) study: Protocol for a multi‐centre, observational research study and development of a consent‐for‐contact research platform

por Hampton, James S., Koo, Sara, Dobson, Christina, Stewart, Christopher J., Neilson, Laura J., Montague, Kyle, Mitra, Suparna, Whelpton, John, Addison, Caroline, Kelly, Phil, Rushton, Stephen, Hull, Mark A., Sharp, Linda, Rees, Colin J.
Publicado 2022

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion

por Verghese, Eldo T, Drury, Ruth, Green, Caroline A, Holliday, Deborah L, Lu, Xiaomei, Nash, Claire, Speirs, Valerie, Thorne, James L, Thygesen, Helene H, Zougman, Alexandre, Hull, Mark A, Hanby, Andrew M, Hughes, Thomas A
Publicado 2013